NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Understanding Mild Cognitive Impairment and the Promise of TMS Therapy
Introduction: Mild Cognitive Impairment (MCI) is a condition that lies between the normal cognitive decline associated with aging and more [...]
Central Pain and TMS Therapy: A Path to Relief
Introduction: Central Pain Syndrome is a challenging neurological condition, characterized by persistent pain that originates from the central nervous system. [...]
Chronic Inflammation vs. Junk Food: The Hidden Health Threat Revealed
Introduction: In the realm of health hazards, junk food often takes center stage, but a stealthier foe may be lurking [...]
Discover Relief from Tinnitus with TMS Therapy in Palm Harbor, FL
Introduction: Tinnitus, often described as the perception of noise or ringing in the ears, can be a persistent and challenging [...]
Find Relief for Tinnitus with TMS Therapy at Countryside Neurology in Palm Harbor, FL
Introduction: Tinnitus, characterized by the perception of noise or ringing in the ears, affects many individuals, with approximately 15 to [...]
Meet Dr. Ardeshir Khademi – Your Trusted Neurologist and TMS Specialist in Palm Harbor, FL
Looking for an experienced and board-certified neurologist to address your health concerns? Dr. Ardeshir Khademi at Countryside Neurology in Palm [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social